The lack of veracity of the content of the products sold with cannabidiol (CBD), oils, fresh, cosmetics, is the cause of a new crusade against cannabis.
In Britain each of the brands sold today must be registered by March 2021, otherwise they will be necessarily removed from the shelves.
The Food Standard Agency (FSA) also announced that “products should not be used in conjunction with other medications.” Despite the commercial success of CBD-based products in Britain, none have a sanitary permit.
For a couple of years, cannabidiol-based products (CBD) whose properties have been recognized worldwide, are freely sold in some pharmacies, convenience stores and in health fairs.
In the analysis tests that have been done both in the United States and in Europe and the United Kingdom, zero or few traces of CBD have been found in the products, as well as, many of them are sold with different counterfeit labels. The authorities also want to approve products with 0% Tetrahydrocannabinol (THC).
“The industry has to provide information on the safety and content of the products with a deadline of March 2021, or the products will be removed from the shelves,” said Emily Miles, FSA spokesperson.
The success of the CBD has been thanks to the fact that many people report great results in their health after a few months of use. However, for legal producers it is prohibited to make any mention of the therapeutic effects of this substance.